RxDoctor Payments Data

Gretchen Korver, MD

Dermatology · Reno, NVNPI 1164456414

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.1% of the total across 363 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 25.5% of the total.

$8,336in general payments, 2019–2025

Across 363 payments — averaging $22.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$718
  • Sun Pharmaceutical Industries Inc.$709
  • Amgen$632
  • Incyte Corporation$558
  • UCB, Inc.$543
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$8,00896%
  • Education$3284%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,336 in reported general payments places this provider in the 65th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$264,180
Medicare patients
729
Services billed
3,846

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate79$3,722
Calcipotriene37$3,508
Fluorouracil64$3,301
Tacrolimus17$2,135
Ketoconazole90$1,762
Metronidazole38$1,543
Hydroxychloroquine Sulfate16$1,482
ValacyclovirValacyclovir Hcl76$1,096
Fluocinolone Acetonide16$887
Triamcinolone Acetonide124$826
Azelaic Acid11$628
Doxycycline Hyclate38$608
Hydrocortisone43$273
Clindamycin Phosphate14$237
Nystatin16$233

Paid to pharmacies, not to this prescriber.

Other dermatology in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →